The word “Amicogen” consists of the meaning of friend, “AMICO”
in Latin and of gene, “GENE”. We developed innovative biocatalysts
and proteins by applying our proprietary i DNA Evolution™ Technology.
We are a “Bioengineering company just like a Sincere Friend”
who contributes to the human health and the preservation of environment.
Amicogen Biotech R&D Center is expanding its R&D field based on
bio-platform technology, and researchers account for 30% of all employees.
We will lead the Industrial Biotechnology to develop new technologies
that can drive the development of humanity and society,
one step further than others.
Amicogen has developed Special Enzymes for industrial and pharmaceutical products based on the i DNA evolution™.
We want to contribute to the sustainable growth and lifelong health
of humanity by developing New Bio-Ingredientfor Health functional foods
with Special Enzymes and Protein Purification Resin.
As Amicogen started as a bio-venture company, we have focused on
the core competence of R&D and are pursuing sustainable growth
in innovative technologies and products. To increase the value
of enterprise and shareholder, we are continually strengthening our core competencies such as specialty enzyme business, healthcare, protein
purification resin business and others.
Amicogen promotes various activities to realize the value of contributing
to the protection of human health and the environment.
Amicogen is positioning itself as a global biotechnology company
through growth and leaps to create new values.
Amicogen has developed bio innovative technologies and operated the businesses that consider humankind and environment from the perspective of sustainability for the past 20 years. We will continue sustainable development based on Amicogen's environmental soundness, social responsibility and sustainable innovative technology.
Amicogen produces new technologies and values based on
creative thinking and constant technological innovation through human
oriented management. We do our best to ensure that talented individuals
with unique skills and abilities can demonstrate their abilities
according to the nature of their duties.
Amicogen produces new technologies and values based on
creative thinking and constant technological innovation through human
oriented management. We do our best to ensure that talented individuals
with unique skills and abilities can demonstrate their abilities
according to the nature of their duties.
Amicogen will try our best to maximize our shareholders' value
and realize the full potential of the company.
2017-07-21
신주 발행가액 확정 공고
신주 발행가액 확정 공고
당사는 금번 유상증자 관련 최종 발행가가 확정됨에 따라 다음과 같이 공고합니다.
- 다 음 -
1. 신주의 확정 발행가액 : 보통주식 1주당 29,300원
2. 청약 증거금 : 보통주식 1주당 29,300원(청약금액의 100%)
3. 구주주 청약일 : 2017년 07월 25일 ~ 2017년 07월 26일 (2일간)
4. 일반공보 청약일 : 2017년 07월 28일 ~ 2017년 07워 31일 (2일간)
5. 기타사항
- 확정 발행가액은 1차 발행가액과 2차 발행가액 중 낮은 가액으로 합니다. 다만 '자본시장과 금융투자업에 관한 법률' 제165조의6 제2항 및 '증권의 발행 및 공시등에 고나한 규정' 제5-15조의2 제1항 제1호에 의거하여 1차 발행가액과 2차 발행가액 중 낮은 가액이 청약일전 과거 제3거래일부터 제5거래일까지의 가중산술평균주가에서 40% 할인율으 적용하여 산정한 가격보다 낮은 경우 청약일전 과거 제3거래일부터 제5거래일까지의 가중산술평균주가에서 40% 할인율을 적용하여 산정한 가격을 확정발행가액으로 합니다. (단, 호가단위 미만은 호가단위로 절상함)
▶ 확정 발행가액 = Max(Min(1차 발생가액, 2차 발행가액), 청약일전 과거 제3거래일부터 제5거래일까지의 가중산술평균주가의 60%)
- 일반공모 발행가액은 우리사주조합 및 구주주 청약시에 적용된 확정발행가액을 동일하게 적용합니다.
2017년 07월 21일
아미코젠 주식회사
대표이사 신 용 철